Da: California Books, Miami, FL, U.S.A.
EUR 46,03
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 47,76
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 125 pages. 6.00x0.29x9.00 inches. In Stock.
Condizione: New.
Da: Majestic Books, Hounslow, Regno Unito
EUR 72,96
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 74,43
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Da: PBShop.store US, Wood Dale, IL, U.S.A.
EUR 60,81
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 59,13
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Da: preigu, Osnabrück, Germania
EUR 49,50
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Multi Omics Integration in Cancer Therapeutics | Network Driven Multi Omics Strategies for Overcoming Therapeutic Resistance | Manisha Chhikara | Taschenbuch | Englisch | 2026 | Eliva Press | EAN 9789999338677 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 59,71
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cancer is no longer understood as a disease driven by isolated genetic mutations, but as a dynamic and adaptive biological system shaped by genomic instability, transcriptional reprogramming, proteomic signaling networks, metabolic rewiring, and microenvironmental interactions. Multi-Omics Integration in Cancer Therapeutics explores how the convergence of genomics, transcriptomics, proteomics, metabolomics, and epigenomics is transforming the landscape of oncology research and clinical care. This book provides a comprehensive framework for understanding how diverse molecular layers can be integrated to uncover causal disease mechanisms, identify actionable targets, and overcome therapeutic resistance. It highlights cutting-edge technologies including high-throughput sequencing, single-cell profiling, spatial transcriptomics, and artificial intelligence-driven analytics. Emphasis is placed on network biology approaches that reconstruct signaling circuits and predict drug responses within heterogeneous tumor ecosystems. Bridging molecular discovery with clinical translation, the text discusses biomarker development, molecular tumor boards, precision drug design, and systems-level strategies for personalized therapy. Through a synthesis of experimental evidence, computational modeling, and translational insights, this volume equips researchers, clinicians, and pharmaceutical scientists with the tools needed to harness integrative multi-omics for next-generation cancer therapeutics. Designed for advanced students, oncology researchers, and professionals in pharmaceutical and biomedical sciences, this book presents a forward-looking vision of precision oncology where data integration drives durable and individualized cancer treatment strategies.